A soon-to-be-published clinical study sheds some more positive light on the potential weight loss benefits of chitosan.
A soon-to-be-published clinical study sheds some more positive light on the potential weight loss benefits of chitosan.
The study explored the effects of KiOnutrime-CsG, a non-animal chitosan ingredient developed by KitoZyme (Belgium), on 86 healthy overweight people aged 18-65. On average, subjects in the treatment group lost an average of 3.2 kg (7.1 lbs) over the course of a 90-day KiOnutrime-CsG regiment, according to a press release.
Chitosan is biopolymer that is traditionally extracted from crustacean shells, but KitoZyme’s non-animal chitosan is instead derived from the cell walls of the fungus Aspergillus niger. The company says it is odorless, tasteless, and dissolves in just 10 minutes in the stomach-making it suitable for use almost immediately before a meal.
Study Design
The multi-center, single-blind study included overweight subjects with a body mass index between 26 and 35 at the start of the trial, but who were otherwise healthy. Subjects were given either five 500-mg capsules of KiOnutrime-CsG or a placebo to take daily for 90 days. They maintained regular diet and exercise patterns and kept a diary to record their experiences. 86 people completed the study, out of 96 enrolled.
Over the 90-day period, the chitosan group did experience a statistically significant “gradual reduction” in body weight that averaged 3.2 kg, compared to no significant change in the placebo group. The treatment group also experienced a significant reduction in average body fat, as well as upper abdominal, hip, and waist circumference, according to a press release.
“The results of this study, which will be published shortly in a peer-reviewed journal, demonstrate the clear benefits of KiOnutrime-CsG and the significant potential it offers in weight management applications globally,” says Francois Luthers, sales and marketing director, KitoZyme.
KiOnutrime-CsG has GRAS status in the United States.
Read more:
Protein Is Weight Management’s Good News
Hoodia Supplementation May Support Weight Loss: Consumer Trial
Whey Protein May Preserve Lean Muscle during Weight Loss
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Photo © iStockphoto.com/energyy
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.